Should adjuvant chemotherapy be formally studied among patients found to have pelvic lymph node metastases following radical hysterectomy with lymphadenectomy for early-stage cervical cancer?
J Gynecol Oncol
.
2021 Jul;32(4):e62.
doi: 10.3802/jgo.2021.32.e62.
Epub 2021 Apr 19.
Authors
Alyssa C Bujnak
1
,
Krishnansu S Tewari
2
Affiliations
1
Division of Gynecologic Oncology, University of California, Irvine Medical Center, Irvine, CA, USA.
2
Division of Gynecologic Oncology, University of California, Irvine Medical Center, Irvine, CA, USA. ktewari@uci.edu.
PMID:
33908714
PMCID:
PMC8192234
DOI:
10.3802/jgo.2021.32.e62
No abstract available
Publication types
Editorial
Comment
MeSH terms
Chemotherapy, Adjuvant
Female
Humans
Hysterectomy
Lymph Node Excision
Lymph Nodes
Lymphatic Metastasis
Uterine Cervical Neoplasms* / surgery